Market Overview:
The global renal disease treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of renal diseases, rising geriatric population, and technological advancements in the field of renal disease treatment. The global renal disease treatment market is segmented on the basis of type into acute kidney problems, chronic kidney diseases, and others. The chronic kidney diseases segment is expected to account for the largest share of the global renal disease treatment market in 2018. This can be attributed to factors such as increasing prevalence of diabetes and hypertension, which are major risk factors for chronic kidney diseases. On the basis of application, the global renal disease treatment market is segmented into hospitals, clinics, research centers, and other applications.
Product Definition:
Renal Disease Treatment is a medical term that refers to the various methods and therapies used to treat diseases or disorders of the kidneys. The importance of Renal Disease Treatment lies in its ability to preserve kidney function and prevent further damage, which can lead to serious health complications.
Acute Kidney Problems:
Acute kidney problems are also known as renal failure. It is a medical condition in which the kidneys do not work properly due to loss of blood flow and other factors. The normal function of the kidney is to filter blood and remove waste products from it. When this process is not carried out effectively, then wastes build up in the body and can lead to many diseases including diabetes, high blood pressure, heart disease, stroke along with acute kidney problems (AKP).
Chronic Kidney Diseases:
Chronic kidney diseases are a group of disorders that damage the kidneys over a period of time. There are various types of CKD’s such as primary, secondary, andtertiary (advanced) CKD. The major symptoms associated with these diseases include chronic urinary frequency, urgency to urinate frequently, blood in urine or dark colored urine etc.
Application Insights:
The acute kidney problems segment dominated the global renal disease treatment market in 2017. This can be attributed to the rising prevalence of chronic kidney diseases and other factors such as advanced healthcare infrastructure, high standard of living, and availability of effective treatments for various conditions. According to a study published by NCBI in 2018, around 60% of patients suffering from CKD are receiving outpatient care which is a major factor contributing towards segment growth.
Furthermore, increasing R&D activities pertaining to new drug development for treating acute kidney failure will boost market growth during the forecast period. For instance, according to data published by EurekAlert!, since 2012 till date more than 200 clinical trials have been conducted for developing drugs that could treat acute Kidney Failure (AKF). Out of which approximately 120 are still ongoing and 40 have been completed so far.
Regional Analysis:
North America dominated the global renal disease treatment market in 2017. This can be attributed to the presence of well-established healthcare facilities, availability of advanced medical products and devices, high patient awareness levels coupled with relatively higher healthcare expenditure levels in this region as compared to other regions. In addition, rise in prevalence of chronic kidney diseases due to sedentary lifestyle and genetic factors is expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing its large population base suffering from various forms of kidney disorders coupled with rising disposable income level among patients which will lead them opt for expensive treatment options over heretofore unaffordable ones thus driving demand for renal disease treatments across this region.
Growth Factors:
- Increasing incidence of renal diseases
- Growing awareness about renal diseases and their treatment options
- Rising demand for better and more effective renal disease treatments
- Technological advancements in the field of renal disease treatment
- Growing number of research and development activities focused on renal disease treatment
Scope Of The Report
Report Attributes
Report Details
Report Title
Renal Disease Treatment Market Research Report
By Type
Acute Kidney Problems, Chronic Kidney Diseases, Others
By Application
Hospital, Clinic, Research Center, Other
By Companies
Abbott, Amgen, Baxter, Bristol-Myers Squibb Company, Keryx Biopharmaceuticals, NephroGenex, Novartis AG, Pfizer, Sanofi, Shire Pharmaceuticals Limited, CTI BioPharma Corp, Merck, Prolong Pharmaceuticals, VESSL Therapeutics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
210
Number of Tables & Figures
147
Customization Available
Yes, the report can be customized as per your need.
Global Renal Disease Treatment Market Report Segments:
The global Renal Disease Treatment market is segmented on the basis of:
Types
Acute Kidney Problems, Chronic Kidney Diseases, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Research Center, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Amgen
- Baxter
- Bristol-Myers Squibb Company
- Keryx Biopharmaceuticals
- NephroGenex
- Novartis AG
- Pfizer
- Sanofi
- Shire Pharmaceuticals Limited
- CTI BioPharma Corp
- Merck
- Prolong Pharmaceuticals
- VESSL Therapeutics
Highlights of The Renal Disease Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Acute Kidney Problems
- Chronic Kidney Diseases
- Others
- By Application:
- Hospital
- Clinic
- Research Center
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Renal Disease Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Renal disease treatment typically includes medications to control the symptoms of the disease and treatments to improve kidney function.
Some of the major players in the renal disease treatment market are Abbott, Amgen, Baxter, Bristol-Myers Squibb Company, Keryx Biopharmaceuticals, NephroGenex, Novartis AG, Pfizer, Sanofi, Shire Pharmaceuticals Limited, CTI BioPharma Corp, Merck, Prolong Pharmaceuticals, VESSL Therapeutics.
The renal disease treatment market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Renal Disease Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Renal Disease Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Renal Disease Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Renal Disease Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Renal Disease Treatment Market Size & Forecast, 2018-2028
4.5.1 Renal Disease Treatment Market Size and Y-o-Y Growth
4.5.2 Renal Disease Treatment Market Absolute $ Opportunity
Chapter 5 Global Renal Disease Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Renal Disease Treatment Market Size Forecast by Type
5.2.1 Acute Kidney Problems
5.2.2 Chronic Kidney Diseases
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Renal Disease Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Renal Disease Treatment Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Research Center
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Renal Disease Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Renal Disease Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Renal Disease Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Renal Disease Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Renal Disease Treatment Market Size Forecast by Type
9.6.1 Acute Kidney Problems
9.6.2 Chronic Kidney Diseases
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Renal Disease Treatment Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Research Center
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Renal Disease Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Renal Disease Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Renal Disease Treatment Market Size Forecast by Type
10.6.1 Acute Kidney Problems
10.6.2 Chronic Kidney Diseases
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Renal Disease Treatment Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Research Center
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Renal Disease Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Renal Disease Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Renal Disease Treatment Market Size Forecast by Type
11.6.1 Acute Kidney Problems
11.6.2 Chronic Kidney Diseases
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Renal Disease Treatment Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Research Center
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Renal Disease Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Renal Disease Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Renal Disease Treatment Market Size Forecast by Type
12.6.1 Acute Kidney Problems
12.6.2 Chronic Kidney Diseases
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Renal Disease Treatment Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Research Center
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Renal Disease Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Renal Disease Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Renal Disease Treatment Market Size Forecast by Type
13.6.1 Acute Kidney Problems
13.6.2 Chronic Kidney Diseases
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Renal Disease Treatment Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Research Center
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Renal Disease Treatment Market: Competitive Dashboard
14.2 Global Renal Disease Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Amgen
14.3.3 Baxter
14.3.4 Bristol-Myers Squibb Company
14.3.5 Keryx Biopharmaceuticals
14.3.6 NephroGenex
14.3.7 Novartis AG
14.3.8 Pfizer
14.3.9 Sanofi
14.3.10 Shire Pharmaceuticals Limited
14.3.11 CTI BioPharma Corp
14.3.12 Merck
14.3.13 Prolong Pharmaceuticals
14.3.14 VESSL Therapeutics
